Suppr超能文献

静息淋巴细胞激酶(Rlk/Txk)使YVKM基序磷酸化,并调节PI 3激酶与T细胞抗原CTLA-4的结合。

Resting lymphocyte kinase (Rlk/Txk) phosphorylates the YVKM motif and regulates PI 3-kinase binding to T-cell antigen CTLA-4.

作者信息

Schneider H, Schwartzberg P L, Rudd C E

机构信息

Department of Cancer Immunology and AIDS, Harvard Medical School, Boston, Massachusetts, 02115, USA.

出版信息

Biochem Biophys Res Commun. 1998 Nov 9;252(1):14-9. doi: 10.1006/bbrc.1998.9559.

Abstract

CTLA-4 and CD28 are differentially expressed on T-cells. They bind to a common ligand B71/2 (CD80/86), however with different avidities. Unlike CD28 which augments the T-cell response, CTLA-4 operates predominately as a negative regulator of T-cell proliferation. The mechanism by which CTLA-4 can generate these intracellular signals is unclear. Little is known regarding the identity of the protein-tyrosine kinase(s) responsible for CTLA-4 phosphorylation and thus creating conditions for the reported binding to PI 3-kinase and the protein tyrosine phosphatase SHP-2. In this study, we demonstrate that Rlk (resting lymphocyte kinase) is capable of phosphorylating CTLA-4 at the YVKM motif. Consistent with this finding, Rlk is capable of providing conditions for the binding of the SH2 domains of PI 3-kinase to the receptor. CTLA-4 is therefore the first known substrate for Rlk suggesting the possibility that this kinase may participate in CTLA-4 function.

摘要

CTLA-4和CD28在T细胞上呈差异表达。它们与共同配体B71/2(CD80/86)结合,但亲和力不同。与增强T细胞反应的CD28不同,CTLA-4主要作为T细胞增殖的负调节因子发挥作用。CTLA-4产生这些细胞内信号的机制尚不清楚。关于负责CTLA-4磷酸化从而为所报道的与PI 3激酶和蛋白酪氨酸磷酸酶SHP-2结合创造条件的蛋白酪氨酸激酶的身份知之甚少。在本研究中,我们证明Rlk(静息淋巴细胞激酶)能够在YVKM基序处磷酸化CTLA-4。与这一发现一致,Rlk能够为PI 3激酶的SH2结构域与受体的结合提供条件。因此,CTLA-4是Rlk的首个已知底物,提示该激酶可能参与CTLA-4功能的可能性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验